Related Posts
Why biological data matters more in AI drug discovery
- admin
- August 3, 2026
- 6 min read
- 0
GSK has entered into a research collaboration with British biotechnology company Relation Therapeutics worth up to $110 million, expanding the companies’ existing work in AI-assisted drug discovery. Under the agreement, Relation will generate large-scale datasets measuring how human cells respond to genetic changes and drug interventions. The data will be used to train AI models […]
[News] For Most of the World, Open-Source AI Is the Only Way Forward
- admin
- June 29, 2026
- 1 min read
- 0
Yann LeCun, speaking at the UN Open‑Source Week, argued that proprietary AI is prohibitively expensive and dangerously centralized, making open‑source AI the sole path to global AI sovereignty, cultural and linguistic diversity, and long‑term safety. He warned that domination by a few Western and Chinese firms would threaten democracy and human rights, and urged nations—especially […]
Microsoft is pulling the plug on Publisher. What now?
- admin
- September 21, 2026
- 7 min read
- 0
It’s the end of a very long era: As of October 2026, Microsoft Publisher, in the company’s words, “will reach its end of life.” That makes it 35 years since the desktop publishing tool was launched back in 1991. What does reaching end of life mean? That depends on what version of Publisher you use. […]